DCG IV
CAS: 147782-19-2
Rif. 3D-XFA78219
| 5mg | Prezzo su richiesta | ||
| 10mg | Prezzo su richiesta | ||
| 25mg | Prezzo su richiesta | ||
| 50mg | Prezzo su richiesta |
Informazioni sul prodotto
- (1R)-3-[(S)-amino(carboxy)methyl]cyclopropane-1,2-dicarboxylic acid
- (1R,2R)-3-[(S)-Aminocarboxymethyl]-1,2-cyclopropanedicarboxylic acid
- (2S,2'R,3'R)-2-(2',3'-Dicarboxycyclopropyl)Glycine
- 1,2-Cyclopropanedicarboxylic acid, 3-(aminocarboxymethyl)-, [1R-[1α,2β,3α(S*)]]-
- 1,2-Cyclopropanedicarboxylic acid, 3-[(S)-aminocarboxymethyl]-, (1R,2R)-
- 2-(2,3-Dicarboxycyclopropyl)Glycine
- 3-[Amino(Carboxy)Methyl]Cyclopropane-1,2-Dicarboxylic Acid
- DCG-IV
DCG IV is a selective metabotropic glutamate receptor agonist that has been shown to have neuroprotective properties. DCG IV was developed by the National Institutes of Health and may be useful in the treatment of Parkinson's disease, Alzheimer's disease, stroke, epilepsy, and traumatic brain injury. In animal models, DCG IV has been shown to protect neurons against neuronal death induced by pharmacological agents or glutamate. DCG IV also reduces locomotor activity and cyclase activity in rats. The neuroprotective effects of DCG IV are believed to be due to its ability to stimulate the release of neurotrophic factors such as brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF).
Proprietà chimiche
Richiesta tecnica su: 3D-XFA78219 DCG IV
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.
